Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association.

Journal Article (Journal Article;Review)

The widespread use of cardiac implantable electronic devices and wearable monitors has led to the detection of subclinical atrial fibrillation in a substantial proportion of patients. There is evidence that these asymptomatic arrhythmias are associated with increased risk of stroke. Thus, detection of subclinical atrial fibrillation may offer an opportunity to reduce stroke risk by initiating anticoagulation. However, it is unknown whether long-term anticoagulation is warranted and in what populations. This scientific statement explores the existing data on the prevalence, clinical significance, and management of subclinical atrial fibrillation and identifies current gaps in knowledge and areas of controversy and consensus.

Full Text

Duke Authors

Cited Authors

  • Noseworthy, PA; Kaufman, ES; Chen, LY; Chung, MK; Elkind, MSV; Joglar, JA; Leal, MA; McCabe, PJ; Pokorney, SD; Yao, X; American Heart Association Council on Clinical Cardiology Electrocardiography and Arrhythmias Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council,

Published Date

  • December 17, 2019

Published In

Volume / Issue

  • 140 / 25

Start / End Page

  • e944 - e963

PubMed ID

  • 31694402

Pubmed Central ID

  • PMC8438789

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIR.0000000000000740


  • eng

Conference Location

  • United States